Daniel Jachimowicz
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA Research and Splicing
- RNA modifications and cancer
- Metabolomics and Mass Spectrometry Studies
Papers in
-
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 1
- Cancer, Hypoxia, and Metabolism 1
-
- Circular RNAs in diseases 1
- Co-authors
- Subazini Thankaswamy Kosalai (2 shared papers)Anna J. Żaczek (1 shared paper)Sylwia Łapińska‐Szumczyk (1 shared paper)Anna Supernat (1 shared paper)Hanna Majewska (1 shared paper)Silke Reischl (2 shared papers)Chandrasekhar Kanduri (2 shared papers)Leo Kurian (1 shared paper)
- Journals
- The International Journal of Biological Markers (1 paper)Oncogene (1 paper)Kidney International (1 paper)Cancer Research (1 paper)
- Partner nations
- SwedenItalySouth Korea
In The Last Decade
Daniel Jachimowicz
4 papers receiving 78 citations
Peers
Comparison fields: 5 of 24
- Cancer Research 55
- Molecular Biology 60
- Nephrology 5
- Neurology 10
- Immunology 8
Countries citing papers authored by Daniel Jachimowicz
This map shows the geographic impact of Daniel Jachimowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Jachimowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Jachimowicz more than expected).
Fields of papers citing papers by Daniel Jachimowicz
This network shows the impact of papers produced by Daniel Jachimowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Jachimowicz. The network helps show where Daniel Jachimowicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Jachimowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 25 | |
| 2 | 2016 | 24 | |
| 3 | 2021 | 18 | |
| 4 | 2024 | 11 |
About Daniel Jachimowicz
Daniel Jachimowicz is a scholar working on Cancer Research, Molecular Biology, Nephrology, Neurology and Pulmonary and Respiratory Medicine, having authored 4 papers that have together received 78 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (2 papers), Plant Disease Resistance and Genetics (1 paper), Neuroblastoma Research and Treatments (1 paper), Dialysis and Renal Disease Management (1 paper), MicroRNA in disease regulation (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Circular RNAs in diseases (1 paper) and Renal and Vascular Pathologies (1 paper). The work is most often cited by research in Cancer Research (55 citations), Molecular Biology (60 citations), Nephrology (5 citations), Neurology (10 citations) and Immunology (8 citations). Daniel Jachimowicz has collaborated with scholars based in Sweden, Italy and South Korea. Frequent co-authors include Subazini Thankaswamy Kosalai, Anna J. Żaczek, Sylwia Łapińska‐Szumczyk, Anna Supernat, Hanna Majewska, Silke Reischl, Chandrasekhar Kanduri, Leo Kurian, Luisa Statello and Matthias Fischer. Their work appears in journals such as The International Journal of Biological Markers, Oncogene, Kidney International and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.